Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 7, Issue 2, 1998, Pages 61-64

  Incerpi, Marc H ^a   Banks, Erika H ^a   Goodwein, Shelley N ^a   Samadi, Ramin ^a   Goodwin, T M ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Antinuclear antibodies; Fetal death; Immunofluorescence pattern

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FETUS; FETUS DEATH; HUMAN; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; COHORT STUDIES; FEMALE; FETAL DEATH; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MEDICAL RECORDS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0031901232     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059809022655     Document Type: Article

References (13)

1. Fraga A, Mintz G, Orozco J: Sterility and fertility rates, fetal wastage, and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1:293-298, 1974.
2. Gimovsky ML, Montoro M, Paul RH: Pregnancy outcome in women with systemic lupus erythematosus. Obstet Gynecol 63:686-692, 1984.
3. Lockshin MD, Qamar T, Druzin ML: Hazards of lupus pregnancy. J Rheumatol [Spec Issue] 14:214-217, 1987.
4. Bagger PV, Andersen V, Baaslund B, Beck B, Hove H, Madsen MH, Petersen J, Phillip J, Schaadt O, Skouby SO, Starup J, Thorsen S, Wiik A: Anticardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE. Acta Obstet Gynecol Scand 72:465-469, 1993.
5. Kaufman RL, Kitridou RC: Pregnancy in mixed connective tissue disease: Comparison with systemic lupus erythematosus. J Rheumatol 9:549-555, 1982.
6. Slate WG, Graham AR: Scleroderma and pregnancy. Am J Obstet Gynecol 101:335-341, 1968.
7. Out H, Bruinse HW, Christiansens G, van Vliet M, deGroot P, Nieuwenhuis K, Derksen R: A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 167:26-32, 1992.
8. Cowchock FS, Smith BJ: Predictors for live birth after unexplained spontaneous abortion: Correlations between immunologic test results, obstetric histories, and outcome of next pregnancy without treatment. Am J Obstet Gynecol 167:1208-1212, 1992.
9. Xu L, Chang V, Murphy A, Rock J, Damewood M, Schlaff W, Zacur H: Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. Am J Obstet Gynecol 163:1493-1497, 1990.
10. Harger J, Rabin B, Marchese S: The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: A prospective controlled study. Obstet Gynecol 73:419-424, 1989.
11. Ostensen M, Lundgren R, Husby G, Rekvig P: Studies on humoral immunity in pregnancy: immunoglobulins, alloantibodies, and autoantibodies in healthy pregnant women and in pregnant women with rheumatoid disease. J Clin Lab Immunol 11:143-147, 1983.
12. Kiuttu J, Hartikainen AL, Makittalo R, Ruuska P: The outcome of pregnancy in anti-nuclear antibody positive women. Gynecol Obstet Invest 37:160-163, 1994.
13. Condemi J: The autoimmune diseases. JAMA 258:2920-2929, 1987.